US20030191525A1

Artifical valve

Claim Score by NHIP

Abstract

Method and apparatus implementing and using techniques for controlling flow in a body lumen, including use of an implantable medical device. The device includes a membrane implantable in a body lumen and invertably deformable between a first position and a second position. The membrane is invertible in response to the direction of fluid flow through the lumen and can be deformable by fluid flow in the body lumen.

US20030191525A1, drawing sheet 1 — Sheet 1 of 15

Term

Term ended

Projected expiry passed 28 April 2022, 4.4 years ago.

39 claims: 4 independent, 35 dependent

1
A medical device, comprising:a membrane implantable in a body lumen and invertably deformable between a first position and a second position, wherein the membrane is invertible in response to the direction of fluid flow through the lumen.
13
A medical system, comprising:a plurality of membranes, each membrane implantable in a body lumen and invertably deformable between a first position and a second position, wherein the membrane is invertible in response to the direction of fluid flow through the lumen.
29
A method, comprising:positioning at least one membrane in a body lumen, each membrane invertably deformable between a first position and a second position, wherein the at least one membrane is invertible in response to the direction of fluid flow through the lumen relative to the membrane in the first position.
34
Broadest claimClaim Score 90, very broad(NHIP)A method of controlling flow in a body lumen, the method comprising:invertably deforming a membrane between a first position and a second position, wherein the membrane is invertible in response to the direction of fluid flow through the lumen.

Independent claims4

41 paragraphs in 5 sections, as filed

FIELD OF THE INVENTION

[0001] This invention relates to medical devices for use in a body lumen.

BACKGROUND

[0002] A venous valve functions to prevent retrograde flow of blood and allow only antegrade flow of blood to the heart. Referring to FIG. 1A, a healthy venous valve 12 is illustrated in a vessel 10. The valve is bicuspid, with opposed cusps 14. In the closed condition, the cusps 14 are drawn together to prevent retrograde flow (arrow 16) of blood. Referring to FIG. 1B, if the valve is incompetent, the cusps 14 do not seal properly and retrograde flow of blood occurs. Incompetence of a venous valve is thought to arise from at least the following two medical conditions: varicose veins and chronic venous insufficiency.

SUMMARY

[0003] This invention relates to medical devices for use with a body lumen. In one aspect, the invention features a medical device including a membrane implantable in a body lumen and invertably deformable between a first position and a second position. The membrane is invertible in response to the direction of fluid flow through the lumen and can be deformable by fluid flow in the body lumen. The membrane can be invertable relative to a radial direction of the body lumen. The membrane can be reversibly deformable between the first position and the second position.

[0004] Implementations can include one or more of the following. The membrane can define a portion of a cone, and can include an anchoring element adjacent a vertex of the cone. The membrane can include an anchoring element configured to embed within the body lumen, or alternatively configured to penetrate through the body lumen. The anchoring element may be, for example, a loop or a barb. The membrane can be formed of a polymer, for example, a polyurethane, polyethylene or fluoroplastic.

[0005] In another aspect, the invention features a medical system. The system includes multiple membranes, each membrane implantable in a body lumen and invertably deformable between a first position and a second position. Each membrane is invertible in response to the direction of fluid flow through the lumen.

[0006] Implementations of the system can include one or more of the following. The membranes can be symmetrically implantable in the body lumen. Each membrane can be invertable relative to a radial direction of the body lumen and can be deformable by fluid flow in the body lumen. At least one membrane can be reversibly deformable between the first position and the second position. At least one membrane can define a portion of a cone and can include an anchoring element adjacent a vertex of the cone. At least one membrane can include an anchoring element configured to embed within the body lumen or alternatively configured to penetrate through the body lumen. The anchoring element can be, for example, a loop or a barb. At least one membrane can be formed of a polymer, for example, a polyurethane, polyethylene or fluoroplastic.

[0007] In another aspect, the invention features a method. The method includes positioning at least one membrane in a body lumen, each membrane invertably deformable between a first position and a second position. Each membrane is invertible in response to the direction of fluid flow through the lumen.

[0008] Implementations of the method can include one or more of the following. The method can include positioning multiple membranes in the body lumen. The multiple membranes can be positioned symmetrically in the body lumen. The method can include penetrating an anchoring element of the at least one membrane through the body lumen or, alternatively, embedding an anchoring element of the at least one membrane into the body lumen.

[0009] In another aspect, the invention features a method of controlling flow in a body lumen. The method includes invertably deforming a membrane between a first position and a second position, the membrane being invertible in response to the direction of fluid flow through the lumen. Implementations can include one or more of the following. The membrane in the second position and a portion of the body lumen can define a cavity. Deformation of the membrane can be relative to a radial axis of the body lumen. The membrane can be deformable by fluid flow in the body lumen. The membrane in the first position and the membrane in the second position can be approximately mirror images of each other. The method can further include invertably deforming a plurality of membranes.

[0010] Embodiments may have one or more of the following advantages. One or more invertible membranes, which can function as artificial valve cusps, can be implanted at a treatment site using a catheter. As such, implantation is minimally invasive and avoids surgery and the possibility of the inherent complications. The membrane is fabricated from a polymer such as a polyurethane, polyethylene or fluoroplastic, which materials are more easily accessible than a natural tissue excised from an animal, and can be manufactured with consistency and efficiency that could be more difficult or more expensive using a natural tissue.

[0011] Other features, objects, and advantages of the invention will be apparent from the description and drawings, and from the claims.

DESCRIPTION OF DRAWINGS

[0012]FIGS. 1A and 1B are illustrations of a venous valve and an incompetent venous valve, respectively.

[0013]FIGS. 2A, 2B, and 2C are partial perspective views of an embodiment of a valve cusp.

[0014]FIG. 3 is a cross-sectional view of the valve cusp of FIG. 2A, taken along line 3-3.

[0015]FIG. 4 is a cross-sectional view of the valve cusp of FIG. 2C, taken along line 4-4.

[0016]FIGS. 5A, 5B, 5C, 5D and 5E are schematic views of an embodiment of a method for implanting a valve cusp.

[0017]FIGS. 6A and 6B are partial perspective views of an embodiment of a valve cusp.

[0018]FIGS. 7A and 7B are partial perspective views of an embodiment of a valve cusp.

[0019]FIG. 8 is a cross-sectional view of the valve cusp of FIG. 7A, taken along line 8-8.

[0020]FIG. 9 is a cross-sectional view of the valve cusp of FIG. 7A, taken along line 9-9.

[0021]FIG. 10 is a partial perspective view of an embodiment of an anchoring element.

[0022]FIG. 11 is a partial perspective view of an embodiment of an anchoring element.

DETAILED DESCRIPTION

[0023] Referring to FIGS. 2A-2C through FIG. 4, a pair of artificial valve cusps 30 are illustrated positioned within a vessel 46, e.g., a vein. Cusps 30 can be positioned upstream or downstream relative to an incompetent venous valve, such as the valve shown in FIG. 1B. Each artificial valve cusp 30 includes at least one anchoring element 38 attached to an invertable portion 42, here, an approximately triangular, flexible membrane. Anchoring element 38 is generally configured to hold invertable portion 39 at a desired location in vessel 46. For example, anchoring element 38 can embed itself within a wall 44 of vessel 46, or penetrate through the wall to secure cusp 30 to the vessel. Invertable portion 42 is capable of deforming between a first position and a second position, e.g., between an opened condition and a closed position, in response to flow of body fluid in vessel 46 to allow or to reduce the flow in the vessel.

[0024] Referring particularly to FIG. 2A and FIG. 3, the cusps 30 are shown in a first position in which each cusp 30 forms an approximate semi-cone, such that an opening 50 is formed by the curved surfaces of the cusps 30. The opening 50 allows antegrade flow of a fluid through the vessel in the direction indicated by arrow 48. The membranes of invertable portions 42 are relatively thin and can conform closely to the vessel wall 44 to maximize the size of opening 50. However, each cusp 30 is also held slightly away from the wall 44 of the vessel 46 by the anchoring element 38, such that a gap 52 is formed between the invertable portion 42 and the wall 44.

[0025] Referring particularly to FIG. 2B, retrograde flow of fluid (arrows 51) in the vessel can accumulate in the gap 52 and exert pressure on the invertable portion 42 of the cusp 30. Since invertable portion 42 is flexible, it can deform under the exerted pressure and invert to form another approximate semi-cone, as shown in FIG. 2C. That is, each cusp 30 forming a first semi-cone in the first position can invert or flip relative to a radial axis of vessel 46 to form a second semi-cone that is approximately the mirror image of the first semi-cone. As the interior 32 of the second semi-cone accumulates retrograde flowing fluid, pressure is exerted on the interior of cusp 30, causing the cusp to move away from the wall 44 of the vessel. As a result, the space 53 between the two cusps 30 narrows, the size of opening 50 decreases, and fluid flow through the vessel and past the cusps is reduced (FIG. 4).

[0026] The cusps 30 can remain in the second position until antegrade fluid flow exerts sufficient pressure on the surface of cusps 30 opposite interior 32 and inverts the cusps to the first position. Thus, cusps 30 provide an artificial valve that automatically responds to the flow of fluid or pressure changes in vessel 46.

[0027]FIGS. 5A to 5E show one method of positioning cusps 30 at a treatment site in vessel 46 using a catheter 18 that may be delivered into the vessel 46 percutaneously. The catheter 18 is generally adapted for delivery through the vessel 46, e.g., using a guidewire. Catheter 18 includes a long, flexible body having a central portion 21, and a retractable sheath 22 over the central portion. Referring particularly to FIG. 5B, a cross-sectional view of FIG. 5A taken along line 5-5, two grooves 25 are formed on either side of the central portion 21, and a push rod 28 is positioned inside each of the grooves 25. Each cusp 30 is positioned in a groove 25 in a compacted state and held in place by the retractable sheath 22 until delivery at the treatment site.

[0028] Catheter 18 can be delivered to the treatment site using endoprosthesis delivery techniques, e.g., by tracking an emplaced guidewire with central lumen 101. At the treatment site, the retractable sheath 22 is retracted proximally to form an opening 26 at the end of each groove 25. Referring particularly to FIG. 5C, push rods 28 are used to push each cusp 30 distally toward the opening 26 to push the anchoring element 38 out of the opening 26. The cusps 30 are pushed out of the openings 26 until the anchoring elements 38 secure the cusps 30 to the wall 44 of the vessel 46. For example, the anchoring elements 38 can embed within the wall 44 or penetrate the wall 44 and secure to the exterior of the vessel 46.

[0029] After each cusp 30 is secured to the vessel 46, the retractable sheath 22 is retracted to fully expose the cusps 30 (FIG. 5D). The central portion 21 is then pulled proximally past the flexible (and deflectable) cusps 30 and retracted from the vessel 46 (FIG. 5E). The cusps 30, now secured to the wall 44, can deform between the first and second positions, as described above.

[0030] Cusps 30 are preferably made of a biocompatible material capable of reversible deformation as described above. Each cusp 30 can be formed from a thin, flexible material, such as a polyurethane, polyethylene or fluoroplastic, for example, polytetrafluoroethylene (PTFE). Invertable portion 42 can be formed of one or more materials. For example, invertable portion 42 may include an edge portion that is relatively more flexible or more compliant than another portion of the invertable portion to help the edges meet and seal when the cusps 30 are in the second position. Cusps 30 can include a radiopaque material, such as a polymer including a radiopacifier, e.g., tantalum metal or bismuth oxychloride, for positioning and monitoring the cusps.

[0031] Similarly, anchoring element 38 is preferably biocompatible. The anchoring element 38 can be formed of a relatively rigid material, such as a polymer having suitable hardness, for example, acrylonitrile-butadiene-styrene (ABS). Other materials can be used, such as metals (e.g., tantalum, tungsten or gold), alloys (e.g., stainless steel or Nitinol), and ceramics. Anchoring elements 38 can include a radiopaque material for positioning and monitoring cusps 30. The anchoring element can be embedded in the invertible portion or fixed to a surface of the invertible portion with, for example, adhesive.

[0032] Other Embodiments

[0033] In other embodiments, any number of cusps can be anchored to the wall 44 of the vessel 46 to function as a valve for preventing retrograde flow of blood through the blood vessel 46.

[0034] Referring to FIGS. 6A and 6B, a single cusp 60 can be used. The cusp 60 can be transported to the treatment site and anchored to the wall 44 of a vessel 46 in the same manner as described above using a catheter. In a first position, the cusp 60 forms an approximate semi-cone, with the edges 63 of the semi-cone facing the wall 44 opposite from where the cusp 60 is anchored to the wall 44. The interior of the cone forms a channel 64 allowing fluid flow past the cusp 60. The anchoring element 65 holds the cusp 30 slightly away from the wall 44 such that a gap 66 is formed between the cusp 60 and the wall 44. Retrograde flowing fluid can accumulate in the gap 66 and exert pressure on the cusp 60, deforming the cusp 60 and widening the gap 66 until the pressure on the cusp 60 inverts the cusp. Referring particularly to FIG. 6B, in an inverted position the cusp 60 forms an approximate cone with the wall 44 and accumulates retrograde flowing fluid in a sack 68 formed by the interior of the cone. Accumulated fluid can exert pressure on the cusp 60, causing the cusp 60 to move away from the wall 44. As a result, the space 66 between the cusp 60 and the wall 44 opposite the anchoring element narrows, until the cusp 60 touches the wall 44, in a second position as shown. In the second position, flow is reduced past the cusp 60 relative to the flow when the cusp 60 was in the first position. The cusp 60 remains in the second position until pressure exerted on the cusp 60 by the antegrade flow of fluid is sufficient to invert the cusp 60 to the first position.

[0035] Referring to FIGS. 7A-7B, three cusps 70a-70c can be symmetrically secured to the wall 44 of a vessel 46 in a similar manner as described above. Referring particularly to FIG. 7A, the cusps 70a-70c are shown in first position that does not substantially impede flow of a fluid through the vessel 46. As shown in FIG. 8, the surfaces of the cusps 70a-70c conform to the wall 44 of the vessel 46, allowing a substantial opening 72 for flow past the cusps 70a-70c.

[0036] Each cusp 70a-70c is held away from the wall 44 by anchoring elements 71a-71c, such that a gap 76 is formed between each cusp and the wall 44. As described above, retrograde flowing fluid accumulates in the gap 76 and exerts pressure on the cusp 70, causing the cusp to deform away from the wall 44, until the cusps invert.

[0037] Referring particularly to FIG. 7B, in an inverted position the interior of each cusp 70a-70c accumulates retrograde flowing fluid. Exerting pressure on the cusps causes them to move toward one another, until the cusps 70a-70c meet in a second position and reduce flow past the cusps 70a-70c relative to the when the cusps 70a-70c are in the first position. Referring to FIG. 9, the opening 72 is significantly reduced, thus restricting the fluid flow. The cusps 70a-70c remain in the second position until pressure exerted on the cusps 70a-70c by antegrade flow of fluid inverts the cusps to the first position.

[0038] Although the embodiments above describe a device having one to three cusps, any number of cusps can be used to prevent retrograde flow through a vessel. The cusps can be arranged symmetrically as shown, or can be arranged in any other configuration. Although the embodiments described above included cusps of similar size and configuration, cusps of differing sizes and configurations can be used in conjunction with each other.

[0039] The anchoring element can take a number of different forms that permit the end of the cusp to penetrate the wall of a blood vessel and restrain the end of the cusp from re-entering the vessel. For example, the anchoring element can be a barb element, as shown in the embodiments described above. Alternatively, the anchoring element can be a T-hook device 80 as shown in FIG. 10, wherein T-hook 80 penetrates the wall of a vessel and hooks 82 prevent the anchor from re-entering the vessel. In another embodiment, the anchoring element can define a loop 84, as shown in FIG. 11, wherein the looped end 86 prevents the anchor from re-entering the vessel.

[0040] In other embodiments, a cusp can include more than one anchoring element. A cusp can have other polygonal configurations. For example, a generally rectangular cusp can be secured to a vessel using two anchoring elements adjacent to two corners of the cusp. The cusp can form a semi-cylinder.

[0041] Other embodiments are within the scope of the following claims.

Contents5

Every citation, both ways

Citations
Document	Relation	Office	Cited during
US10517718B2	Cited by	United States of America	Applicant
US9636114B2	Cited by	United States of America	Applicant
US2006142846A1	Cited by	United States of America	Pre-grant
US2022218876A1	Cited by	United States of America	Search report
US8337545B2	Cited by	United States of America	Applicant
US10314704B2	Cited by	United States of America	Search report
US2020170790A1	Cited by	United States of America	Search report
US2006235512A1	Cited by	United States of America	Pre-grant
US7959554B2	Cited by	United States of America	Applicant
US2006212111A1	Cited by	United States of America	Pre-grant
US2011171181A1	Cited by	United States of America	Pre-grant
US9788984B2	Cited by	United States of America	Applicant
US8197534B2	Cited by	United States of America	Applicant
US7871434B2	Cited by	United States of America	Applicant
US9872786B2	Cited by	United States of America	Applicant
US11338064B2	Cited by	United States of America	Search report
US7905826B2	Cited by	United States of America	Applicant
US10940167B2	Cited by	United States of America	Applicant
US8177837B2	Cited by	United States of America	Applicant
US9211182B2	Cited by	United States of America	Applicant
US2006265053A1	Cited by	United States of America	Pre-grant
US9186435B2	Cited by	United States of America	Applicant
US2006253188A1	Cited by	United States of America	Pre-grant
US7795027B2	Cited by	United States of America	Applicant
US8470022B2	Cited by	United States of America	Applicant
US2006116548A1	Cited by	United States of America	Pre-grant
US2009157169A1	Cited by	United States of America	Pre-grant
US2007050014A1	Cited by	United States of America	Pre-grant
US8771340B2	Cited by	United States of America	Applicant
US2010185275A1	Cited by	United States of America	Pre-grant
US2006147433A1	Cited by	United States of America	Pre-grant
JP2018023825A	Cited by	Japan	Search report
US2007027518A1	Cited by	United States of America	Pre-grant
US9414843B2	Cited by	United States of America	Applicant
US2014350661A1	Cited by	United States of America	Pre-grant
US2005096736A1	Cited by	United States of America	Pre-grant
US11406495B2	Cited by	United States of America	Applicant
US2007166395A1	Cited by	United States of America	Pre-grant
US2004049262A1	Cited by	United States of America	Pre-grant
US11672651B2	Cited by	United States of America	Search report
US7387604B2	Cited by	United States of America	Applicant
US11202627B2	Cited by	United States of America	Applicant
US10368862B2	Cited by	United States of America	Applicant
US9402720B2	Cited by	United States of America	Search report
US10624737B2	Cited by	United States of America	Search report
US2006212110A1	Cited by	United States of America	Pre-grant
US9844453B2	Cited by	United States of America	Applicant
EP2982338A2	Cited by	European Patent Office (EPO)	Search report
US10631979B2	Cited by	United States of America	Applicant
US8641776B2	Cited by	United States of America	Applicant
US2014288642A1	Cited by	United States of America	Pre-grant
WO2013119630A1	Cited by	World Intellectual Property Organization (WIPO)	International search
US7981162B2	Cited by	United States of America	Search report
US2011112621A1	Cited by	United States of America	Pre-grant
US11517710B2	Cited by	United States of America	Applicant
US10512751B2	Cited by	United States of America	Applicant
US2007050012A1	Cited by	United States of America	Pre-grant
US7520894B2	Cited by	United States of America	Applicant
US2005143807A1	Cited by	United States of America	Pre-grant
US8834351B2	Cited by	United States of America	Applicant
WO2006125055A2	Cited by	World Intellectual Property Organization (WIPO)	International search
US9017397B2	Cited by	United States of America	Applicant
US8454678B2	Cited by	United States of America	Applicant
US10080677B2	Cited by	United States of America	Applicant
US2011224484A1	Cited by	United States of America	Pre-grant
US7458987B2	Cited by	United States of America	Applicant
US8475512B2	Cited by	United States of America	Applicant
US2009081122A1	Cited by	United States of America	Pre-grant
US10588746B2	Cited by	United States of America	Applicant
US8906083B2	Cited by	United States of America	Applicant
US2009204228A1	Cited by	United States of America	Pre-grant
US2006210597A1	Cited by	United States of America	Pre-grant
US11471568B2	Cited by	United States of America	Search report
US2007004961A1	Cited by	United States of America	Pre-grant
US9585746B2	Cited by	United States of America	Search report
US11577004B2	Cited by	United States of America	Applicant
US7815923B2	Cited by	United States of America	Applicant
WO2006125055A3	Cited by	World Intellectual Property Organization (WIPO)	International search
US11000370B2	Cited by	United States of America	Applicant
EP2809264A4	Cited by	European Patent Office (EPO)	Search report
US9066798B2	Cited by	United States of America	Applicant
US10610357B2	Cited by	United States of America	Applicant
US8303647B2	Cited by	United States of America	Applicant
US10285836B2	Cited by	United States of America	Applicant
US10173027B2	Cited by	United States of America	Applicant
US8444687B2	Cited by	United States of America	Applicant
US7524332B2	Cited by	United States of America	Applicant
US10226256B2	Cited by	United States of America	Applicant
WO2005013857A1	Cited by	World Intellectual Property Organization (WIPO)	International search
EP2379011B1	Cited by	European Patent Office (EPO)	Examiner
EP2982338A3	Cited by	European Patent Office (EPO)	Search report

14 members in 7 offices

This recordMember, by publication datePriority claim

Priority claims2

Priority claims
Document	Office	Kind	Date
11555702	United States of America	A	2002-04-03
US20020115557	–	–	–

Members14

Family members, oldest first
Document	Office	Kind
US2003191525A1	United States of America	A1	2003-10-09
WO03084443A1	World Intellectual Property Organization (WIPO)	A1	2003-10-16
AU2003220646A1	Australia	A1	2003-10-20
US6752828B2	United States of America	B2	2004-06-22
US2004230297A1	United States of America	A1	2004-11-18
EP1489996A1	European Patent Office (EPO)	A1	2004-12-29
US7081131B2	United States of America	B2	2006-07-25
US2006253189A1	United States of America	A1	2006-11-09
EP1489996B1	European Patent Office (EPO)	B1	2007-12-05
AT379999T	Austria	T	2007-12-15
DE60317886D1	Germany	D1	2008-01-17
ES2297147T3	Spain	T3	2008-05-01
DE60317886T2	Germany	T2	2008-12-11
US7682385B2	United States of America	B2	2010-03-23

46 transactions on the USPTO file

Allowed after 1 non-final rejection and 1 final rejection.

Non-final rejections: 1
Final rejections: 1
RCEs: 0
Appeals: 0

Over time

Point at a mark for the transaction

Transactions

Prosecution transactions, newest first
	Event
2012-07-23	Expire Patent
2004-08-18	Post Issue Communication - Certificate of Correction
2004-07-12	Recordation of Patent Grant Mailed
2004-06-22	Patent Issue Date Used in PTA CalculationAllowed
2004-06-03	Issue Notification MailedAllowed
2004-05-17	Receipt into Pubs
2004-05-14	Application Is Considered Ready for Issue
2004-05-05	Issue Fee Payment Verified
2004-05-05	Issue Fee Payment Received
2004-03-19	Receipt into Pubs
2004-02-16	Receipt into Pubs
2004-02-13	Workflow - File Sent to Contractor
2004-02-13	Receipt into Pubs
2004-02-10	Dispatch to Publications
2004-02-05	Mail Notice of AllowanceAllowed
2004-02-05	Notice of Allowance Data Verification CompletedAllowed
2004-02-03	Date Forwarded to Examiner
2004-01-28	Response after Final Action
2003-11-26	Correspondence Address Change
2003-11-26	Change in Power of Attorney (May Include Associate POA)
2003-11-25	Mail Final Rejection (PTOL - 326)Final rejection
2003-11-21	Final RejectionFinal rejection
2003-10-21	Date Forwarded to Examiner
2003-10-06	Workflow - Drawings Finished
2003-10-06	Workflow - Drawings Matched with File at Contractor
2003-10-06	Information Disclosure Statement (IDS) Filed
2003-10-06	Information Disclosure Statement (IDS) Filed
2003-10-06	Response after Non-Final Action
2003-09-24	Change in Power of Attorney (May Include Associate POA)
2003-09-24	Mail-Record Petition Decision of Granted Related to Attorney
2003-09-23	Correspondence Address Change
2003-08-11	Petition Entered
2003-07-02	Mail Non-Final RejectionNon-final rejection
2003-06-26	Non-Final RejectionNon-final rejection
2003-05-27	Case Docketed to Examiner in GAU
2003-05-19	Incoming Letter Pertaining to the Drawings
2003-05-19	Information Disclosure Statement (IDS) Filed
2003-05-19	Information Disclosure Statement (IDS) Filed
2003-04-08	Case Docketed to Examiner in GAU
2002-10-02	Transfer Inquiry to GAU
2002-08-21	Application Dispatched from OIPE
2002-08-13	Application Is Now Complete
2002-07-16	Additional Application Filing Fees
2002-07-16	Applicant has submitted new drawings to correct Corrected Papers problems
2002-04-17	IFW Scan & PACR Auto Security Review
2002-04-03	Initial Exam Team nn

8 legal events, as the office reported them to INPADOC

Over the term

Point at a mark for the event

Events

Legal events, newest first
	Event	Code
2012-08-14	Lapsed due to failure to pay maintenance feeLapsedFP	FP
2012-07-23	Information on status: patent discontinuationPATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362STCH	STCH
2012-06-22	Lapse for failure to pay maintenance feesLapsedLAPS	LAPS
2012-02-06	Maintenance fee reminder mailedREMI	REMI
2007-09-14	Fee paymentFPAY	FPAY
2005-12-08	Fee payment procedurePAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITYFEPP	FEPP
2004-09-14	Certificate of correctionCC	CC
2002-04-03	AssignmentAS	AS